kevin mckernan , the human genome sequencing center at the baylor college of medicine in houston , has quit his job , formed a startup run from his house in marblehead , massachusetts , and announced in a peer-reviewed journal . " this is the beginning of a more scientific approach to the genetics of the species , " richard gibbs , director of life technologies corp. , tells bloomberg . he says he has known mckernan for more than 15 years . " it ’ s about time , " he says , per bloomberg . " we ’ re not going to be able to find a way to make sure that we are going to get to the bottom of the iceberg . " mckernan , 38 , worked on the project from 1996 , when he became the first person to submit a dna test to the plant , which he says is a " draft assembly " that will be tested for cancer , pain and inflammatory diseases , reports the new york times . the company says it 's working with thai law enforcement to figure out what 's going on in the us , but it 's not clear whether it will be rescheduled or if it 's rescheduled to november .
